Toulouse University Hospital (CHU de Toulouse)
Toulouse, 31059, France
NCT Number: NCT03501290
In this study, patients are supposed to take Fortimel® Protein, an Oral Nutritional Supplement (ONS) recommended in case of malnutrition once daily during the study period.
Three visits will be planned for each patient enrolled in the study (baseline visit, visits of follow-up at 4 weeks and 12 weeks). Phone calls will be regularly organized during one month or three months according to the duration of supplementation.
The primary purpose of the OFraDDom study is to assess the compliance with ONS (respect by the patient of the physician's prescription) at the end of the first month.
Data regarding the beneficial effects of ONS, or compliance with ONS in frail elderly population, are very limited. The study could complete knowledge about oral nutritional supplementation in the undernourished frail elderly people and help to demonstrate that oral nutritional supplements have benefits on nutritional status and physical performances in frail elderly people.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Toulouse, 31059, France
For elderly with Protein Energy Malnutrition (PEM) or at nutritional risk, evidences support that Oral Nutritional Supplements (ONS) and dietary counselling can increase dietary intake and improve quality of life. However, data regarding the beneficial effects of ONS, or compliance with ONS in frail elderly population, are very limited. In their RCT, testing the effect of protein supplementation, Tieland and colleagues (7) showed an improvement of SPPB in frail older adults randomized to receive 15 g of supplemental protein daily for 24 weeks compared with the placebo group (p=0.02). Another recent RCT on the effect of a daily supplementation with protein and micronutrients for 12 weeks in 87 frail older adults (usual gait speed <0.6 m/s; MNA < 24) showed that Physical Functioning increased by 5.9% (1 point) in the intervention group, although no change was observed in the control group. SPPB remained stable in the intervention group, although it decreased by 12.5% (1 point) in controls (8).
In this study, patients are supposed to take Fortimel® Protein, an ONS recommended in case of malnutrition once daily during the study period.
Patients fulfilling eligibility criteria will be asked whether they are interested to participate in the study and receive Fortimel® protein. After informed consent, three visits will be planned for each patient enrolled in the study (baseline visit, visits of follow-up at 4 weeks and 12 weeks). Phone calls will be regularly organized during one month or three month according to the duration of supplementation to collect the compliance with ONS and coach patients.
First prescription of the study product will be done for one month. Prescription will be repeated for 2 additional months only after the patient's nutritional status and its global health status, as well as tolerability and compliance to the ONS, were re-assessed during the first follow-up visit at one month.
Data regarding the beneficial effects of ONS, or compliance with ONS in frail elderly population, are very limited. To complete knowledge about oral nutritional supplementation in the undernourished frail elderly people, study purpose is to assess Fortimel® Protein compliance to know if this supplementation is well accepted and what are factors which limit compliance. More, it could help to demonstrate that oral nutritional supplements have benefits on nutritional status and physical performances in frail elderly people.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients are supposed to take Fortimel® Protein once daily during the study period. The prescription is one unit a day.
First prescription of the study product will be done for one month. Prescription will be repeated for 2 additional months only after the patient's nutritional status and its global health status, as well as tolerability and compliance to the ONS, were re-assessed during the first follow-up visit at one month.
Time frame: At the end of the first month : Day 30
Fortimel® compliance as defined as the consumption of at least 75% of the prescribed volume of ONS.
Time frame: Change at one and three months
Fortimel® Compliance as defined as the consumption of at least 75% of the prescribed volume of ONS after 3 months supplementation,
Time frame: Change at one and three months
Body weight evolution measured during the follow up visits at one month and three months,
Time frame: Change at one and three months
Short Physical Performance Battery (SPPB) score (global score and each item)
Time frame: Change at one and three months
MNA scores evolution
Time frame: Change at one and three months
ADL scores evolution
Time frame: Change at one and three months
Fragility : Fried criteria evolution
Time frame: Change at one and three months
EuroQoL scores evolution
Time frame: Change at one and three months
Nutritional history intake evolution
University Hospital, Toulouse
Other
Acronym: OFraDDom
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06975540
Frail Elderly, Frailty
Valencia, Spain
View Trial DetailsNCT01991639
Behavior, Frail Elderly
Vienna, Austria
View Trial DetailsNCT03129269
Alzheimer Disease, Brain Diseases
Toulouse, France
View Trial DetailsNCT05411393
Activities of Daily Living, Frail Elderly
Gainesville, Florida, United States
View Trial Details